✦ LIBER ✦

Viral dynamics and anti-viral pharmacodynamics: rethinking in vitro measures of drug potency

✍ Scribed by Neil M Ferguson; Christophe Fraser; Roy M Anderson

Book ID: 117340476
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 74 KB
Volume: 22
Category: Article
ISSN: 0165-6147
DOI: 10.1016/s0165-6147(00)01615-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-viral Drug Treatment: Dynamics of R

Anti-viral Drug Treatment: Dynamics of Resistance in Free Virus and Infected Cell Populations

✍ Martin A. Nowak; Sebastian Bonhoeffer; George M. Shaw; Robert M. May 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Anti-viral drug treatment of infections with the human immunodeficiency virus type I (HIV-1) usually leads to a rapid decline in the abundance of plasma virus. The effect of single drug therapy, however, is often only short-lived as the virus readily develops drug-resistant mutants. In this paper we

Design of Viral Dynamic Studies for Effi

Design of Viral Dynamic Studies for Efficiently Assessing Potency of Anti-HIV Therapies in AIDS Clinical Trials

✍ Hulin Wu; A. Adam Ding 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Pharmacodynamics of Antiretroviral Agent

Pharmacodynamics of Antiretroviral Agents in HIV-1 Infected Patients: Using Viral Dynamic Models that Incorporate Drug Susceptibility and Adherence

✍ Hulin Wu; Yangxin Huang; Edward P. Acosta; Jeong -Gun Park; Song Yu; Susan L. Ro 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 243 KB

Use of the CD4 in vitro CMI™ platform to

Use of the CD4 in vitro CMI™ platform to measure viral-induced and drug-induced immunosuppression

✍ H. Farzadegan; J. Woodcock; D. Post; R. Kowalski 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 43 KB

In vitro and in vivo anti-herpes viral a

In vitro and in vivo anti-herpes viral activities and biological properties of CV-araU

✍ Noriyuki Ashida; Shinji Sakata; Fumitaka Kano; Makiko Nishitani; Yohko Watanabe; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Dynamic versus static models in cost-eff

Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic

✍ Anna K. Lugnér; Sido D. Mylius; Jacco Wallinga 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

## Abstract Conventional (static) models used in health economics implicitly assume that the probability of disease exposure is constant over time and unaffected by interventions. For transmissible infectious diseases this is not realistic and another class of models is required, so‐called dynamic